VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent builds on Momentum with New $3.6 Million NIH SBIR Grant to fund U.S. clinical trial of breakthrough medical device showing promise in improving dialysis patient outcomes.